Galena Biopharma Inc (NASDAQ:GALE)

Data as of Jan 29
 -0.02 / -1.21%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Galena Biopharma, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. It currently develops peptide antigenbased off the shelf cancer immunotherapies for potential application to treatment of large populations of cancer survivors. The company was founded by Craig Mello on April 3, 2006 and is headquartered in Portland, OR.

Contact Information

Galena Biopharma, Inc.
4640 SW Macadam Avenue
Portland Oregon 97239
P:(855) 855-4253
Investor Relations:
(503) 405-8258



Other institutional9.67%
Mutual fund holders8.47%
Individual stakeholders0.58%

Top Executives

Mark W. SchwartzPresident & Chief Executive Officer
Ryan DunlapSecretary, CAO, Finance Director & Controller
Brian L. HamiltonChief Medical Officer & Executive Vice President
Joseph LasagaVP-Business Development & Alliance Management
Remy BernardaVice President-Marketing & Communications

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.